Serotonin

The vendor opportunity at Serotonin

Serotonin operates in the personal services sector with a total of 11 units, split between 8 franchised locations and 3 company-owned outlets. The system is geographically concentrated, with all mapped units located in Florida. Year-over-year unit growth stands at 33.3%, signaling active expansion from a small base. For software vendors, the immediate addressable market is the 8 franchised units, though the company-owned locations may offer a direct sales pathway to the franchisor. The franchise carries a 7.0% royalty and a 10-year initial term, with a renewal term of 5 years available under specific conditions.

Who controls software purchasing

Based on the 2026 Franchise Disclosure Document, technology decisions appear to be tightly controlled at headquarters. The FDD lists Eric Casaburi as Chief Executive Officer and Matthew Mauriello as Vice President of Business Development. Additional executives include William “Bill” Murray, Chief Learning Officer, and KT Remus, Chief Marketing Officer. In a system of this size, the CEO and VP of Business Development are the most likely points of contact for any enterprise software sale. The operator footprint confirms this centralized dynamic: only 2 operators are mapped, neither of which is a multi-unit franchisee, meaning no franchisee has accumulated enough scale to independently influence procurement.

Mandated and current tech stack

The FDD explicitly mandates two technology systems: SeroConnect and the Serotonin App. No other vendors are named in the disclosure, and the document does not detail whether these systems cover point-of-sale, scheduling, CRM, or other operational functions. For a vendor pitching complementary or replacement software, the presence of mandated systems means any new tool must either integrate with SeroConnect and the Serotonin App or demonstrate a compelling reason for the franchisor to amend its required technology stack. The lack of additional named vendors suggests the current tech ecosystem is narrow and proprietary.

Procurement, renewals, and timing

Item 8 of the FDD, which typically outlines procurement restrictions and designated suppliers, was not extracted in the available data. This means the specific procurement model—whether franchisees must buy from designated suppliers, choose from approved vendors, or operate with open discretion—is not publicly known from the most recent filing. On the renewal side, Item 17 provides clear conditions: franchisees may renew for a successive 5-year term if they provide written notice between 6 and 12 months before expiration, sign the then-current Franchise Agreement (which may have materially different terms), meet all training and capital expenditure requirements, execute a general release, and pay a renewal fee equal to 50% of the then-current Initial Franchise Fee. With a 10-year initial term, natural contract renewal windows are infrequent, but the requirement to sign the current agreement at renewal creates a potential trigger for technology adoption if the franchisor updates its mandated stack.

How to read the Serotonin FDD

The full Serotonin Franchise Disclosure Document, filed with state franchise regulators in 2026, is available below. The document contains detailed information on fees, territory, training, and the franchisor’s obligations. For software vendors, the most relevant sections are Item 8 (procurement restrictions), Item 11 (franchisor assistance and mandated systems), and Item 17 (renewal and modification of the franchise agreement). Reviewing these items will clarify whether the franchisor can compel adoption of new technology at renewal or during the term. For a ranked target list of franchise systems matched to your software category, FranCloud can help you prioritize your outreach.